Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Erectile Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erectile dysfunction markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6...

May 2024 133 pages

Erosive Esophagitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erosive esophagitis markets are expected to exhibit a CAGR of 19.2% during 2024-2034. The erosive esophagitis market has been comprehensively analyzed in IMARC's new report titled 'Erosive...

May 2024 129 pages

Erythema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythema markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The erythema market has been comprehensively analyzed in IMARC's new report titled 'Erythema Market: Epidemiology...

May 2024 137 pages

Erythromelalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major erythromelalgia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.8 Billion by 2034, exhibiting a growth rate (CAGR) of 4.94%...

May 2024 132 pages

Esophageal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal cancer markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.7...

May 2024 137 pages

Esophageal Motility Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal motility disorders markets are expected to exhibit a CAGR of 5.93% during 2024-2034. The esophageal motility disorders market has been comprehensively analyzed in IMARC's new re...

May 2024 130 pages

Esophageal Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major esophageal squamous cell carcinoma markets are expected to exhibit a CAGR of 8.1% during 2024-2034. The esophageal squamous cell carcinoma market has been comprehensively analyzed in IMARC...

May 2024 133 pages

Ewing’s Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ewing’s sarcoma markets reached a value of US$ 47.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 74.5 Million by 2034, exhibiting a growth rate (CAGR) of 4.1%...

May 2024 135 pages

Exanthema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exanthema markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.32% during...

May 2024 134 pages

Exocrine Pancreatic Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exocrine pancreatic insufficiency markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.0 Billion by 2034, exhibiting a growth rat...

May 2024 128 pages

Extensive-Stage Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major extensive-stage small cell lung cancer markets are expected to exhibit a CAGR of 7.6% during 2024-2034. The extensive-stage small cell lung cancer market has been comprehensively analyzed...

May 2024 131 pages

Failed Back Surgery Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major failed back surgery syndrome markets reached a value of US$ 13.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.6 Billion by 2034, exhibiting a growth rate (...

May 2024 129 pages

Fallopian Tube Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fallopian tube cancer markets are expected to exhibit a CAGR of 6.96% during 2024-2034. The fallopian tube cancer market has been comprehensively analyzed in IMARC's new report titled 'Fal...

May 2024 132 pages

Familial Adenomatous Polyposis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial adenomatous polyposis markets are expected to exhibit a CAGR of 4.23% during 2024-2034. The familial adenomatous polyposis market has been comprehensively analyzed in IMARC's new...

May 2024 138 pages

Familial Mediterranean Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial Mediterranean fever markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The familial Mediterranean fever market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Familial Primary Pulmonary Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial primary pulmonary hypertension markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.2 Billion by 2034, exhibiting a grow...

May 2024 133 pages

Fanconi Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fanconi anemia markets reached a value of US$ 49.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 78.8 Million by 2034, exhibiting a growth rate (CAGR) of 4.38%...

May 2024 134 pages

Febrile Neutropenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major febrile neutropenia markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

Fecal Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fecal incontinence markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.8...

May 2024 140 pages

Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major female infertility markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.7...

May 2024 129 pages

Fibrodysplasia Ossificans Progressiva Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibrodysplasia ossificans progressiva markets reached a value of US$ 361.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 503.8 Million by 2034, exhibiting a gr...

May 2024 138 pages

Fibromyalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibromyalgia markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 2.69% dur...

May 2024 135 pages

Filariasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major filariasis markets are expected to exhibit a CAGR of 7.92% during 2024-2034. The filariasis market has been comprehensively analyzed in IMARC's new report titled 'Filariasis Market: Epidem...

May 2024 139 pages

Focal Segmental Glomerulosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major focal segmental glomerulosclerosis markets reached a value of US$ 332.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 578.0 Million by 2034, exhibiting a growt...

May 2024 135 pages

Follicular Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major follicular lymphoma markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 129 pages

Food Allergy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major food allergy markets reached a value of US$ 2,199.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,425.2 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 134 pages

Fragile X Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fragile X syndrome markets reached a value of US$ 43.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 66.9 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 136 pages

Friedreich's Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Friedreich's ataxia markets reached a value of US$ 600.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,710.7 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Frontotemporal Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major frontotemporal dementia markets reached a value of US$ 123.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 596.3 Million by 2034, exhibiting a growth rate (CAG...

May 2024 138 pages

Fuchs Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fuchs dystrophy markets reached a value of US$ 148.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 292.9 Million by 2034, exhibiting a growth rate (CAGR) of 6....

May 2024 131 pages

Functional Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major functional dyspepsia markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 135 pages

Functional Neurological Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major functional neurological disorder markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.1 Billion by 2034, exhibiting a growth ra...

May 2024 130 pages

Fungal Lung Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fungal lung diseases markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The fungal lung diseases market has been comprehensively analyzed in IMARC's new report titled 'Funga...

May 2024 128 pages

Galactosemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major galactosemia markets reached a value of US$ 341.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 501.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.57%...

May 2024 137 pages

Gallbladder Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gallbladder cancer markets reached a value of US$ 51.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 66.8 Million by 2034, exhibiting a growth rate (CAGR) of 2...

May 2024 130 pages

Ganglion Cyst Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ganglion cyst markets are expected to exhibit a CAGR of 5.38% during 2024-2034. The ganglion cyst market has been comprehensively analyzed in IMARC's new report titled 'Ganglion Cyst Marke...

May 2024 129 pages

Gastritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastritis markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The gastritis market has been comprehensively analyzed in IMARC's new report titled 'Gastritis Market: Epidemiol...

May 2024 139 pages

Gastro Esophageal Junction Neuroendocrine Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastro esophageal junction neuroendocrine tumor markets reached a value of US$ 1,059.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,965.3 Million by 2034, e...

May 2024 130 pages

Gastroesophageal Junction Adenocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastroesophageal junction adenocarcinoma markets are expected to exhibit a CAGR of 13.82% during 2024-2034. The gastroesophageal junction adenocarcinoma market has been comprehensively ana...

May 2024 128 pages

Gastroesophageal Reflux Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastroesophageal reflux disease markets are expected to exhibit a CAGR of 1.21% during 2024-2034. The gastroesophageal reflux disease market has been comprehensively analyzed in IMARC's ne...

May 2024 132 pages

Gastrointestinal Stromal Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastrointestinal stromal tumor markets reached a value of US$ 493.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 810.2 Million by 2034, exhibiting a growth ra...

May 2024 128 pages

Generalized Anxiety Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major generalized anxiety disorder markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.4 Billion by 2034, exhibiting a growth rate (CA...

May 2024 138 pages

Generalized Pustular Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major generalized pustular psoriasis markets reached a value of US$ 18.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.5 Billion by 2034, exhibiting a growth rate...

May 2024 139 pages

Genital Herpes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major genital herpes markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The genital herpes market has been comprehensively analyzed in IMARC's new report titled 'Genital Herpes Ma...

May 2024 132 pages

Genital Warts Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major genital warts markets reached a value of US$ 813.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,335.5 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 137 pages

Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major geographic atrophy markets reached a value of US$ 24.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 44.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5...

May 2024 131 pages

Germ Cell Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major germ cell tumor markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.7 Billion by 2034, exhibiting a growth rate (CAGR) of 8.91%...

May 2024 140 pages

Gestational Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gestational diabetes markets are expected to exhibit a CAGR of 4.77% during 2024-2034. The gestational diabetes market has been comprehensively analyzed in IMARC's new report titled 'Gesta...

May 2024 128 pages

Giant Cell Arteritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major giant cell arteritis markets reached a value of US$ 1,130.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,825.2 Million by 2034, exhibiting a growth rate (CA...

May 2024 139 pages

Gingivitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gingivitis markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.27 Billion by 2034, exhibiting a growth rate (CAGR) of 3.85% duri...

May 2024 129 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...